CD274 and neoplasm: With a view to utilizing a-TEA as an effective adjuvant to improve the efficacy of ICB and restore anti-tumor activity, we evaluated the anti-tumor activity of a-TEA-LS, a scalable form of a-TEA (22) in combination with PD-1/PD-L1 blockade in three murine models of mammary carcinoma.